Patent ID: 7235365
Filing Date: 2007-06-26
Classification: A61K,A61P,C07K,C12Q,G01N

Abstract:
1. A method for monitoring a response to a treatment in a subject with a Kaposi's sarcoma-associated herpesvirus (KSHV) associated disorder, comprising contacting a sample from the subject with a monoclonal antibody that specifically binds Kaposi's sarcoma-associated herpesvirus (KSHV) interleukin-6 (vIL-6), wherein the monoclonal is produced by a hybridoma deposited as American Type Culture Collection (ATCC) Deposit No. PTA-2217, PTA-2218, PTA-2219, or PTA-2220 or is a humanized form thereof, detecting the binding of the monoclonal antibody with the sample, wherein binding of the monoclonal antibody to the sample is indicative of the response to the treatment of the subject with the KSHV associated disorder.